Population pharmacokinetic–pharmacodynamic modelling in oncology: a tool for predicting clinical response-Reference-Cited by-同舟云学术

Population pharmacokinetic–pharmacodynamic modelling in oncology: a tool for predicting clinical response

Published:2014-12-19 Issue:1 Volume:79 Page:56-71
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Bender Brendan C.¹,Schindler Emilie¹,Friberg Lena E.¹

Affiliation:

1. Department of Pharmaceutical Biosciences Uppsala University Uppsala Sweden

Funder

Swedish Cancer Society and DDMoRe

European Union's Seventh Framework Programme

EFPIA

Academic and SME partners

Genentech, Inc.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.12258

Reference73 articles.

1. Cancer statistics, 2012

2. Drug development in oncology: classical cytotoxics and molecularly targeted agents

3. FDA.Guidance for industry. Clinical trial endpoints for the approval of cancer drugs and biologics.2007. Available athttp://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071590.pdf(last accessed 7 November 2013).

4. Progression-Free Survival: Meaningful or Simply Measurable?

5. On the Use of Change in Tumor Size to Predict Survival in Clinical Oncology Studies: Toward a New Paradigm to Design and Evaluate Phase II Studies

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Model-informed precision dosing: State of the art and future perspectives;Advanced Drug Delivery Reviews;2024-08

2. Disentangling Anti‐Tumor Response of Immunotherapy Combinations: A Physiologically Based Framework for V937 Oncolytic Virus and Pembrolizumab;Clinical Pharmacology & Therapeutics;2024-07-22

3. Quantification of biochemical PSA dynamics after radioligand therapy with [177Lu]Lu-PSMA-I&T using a population pharmacokinetic/pharmacodynamic model;EJNMMI Physics;2024-04-24

4. New 2-alkoxycyanopyridine derivatives as inhibitors of EGFR, HER2, and DHFR: Synthesis, anticancer evaluation, and molecular modeling studies;Bioorganic Chemistry;2023-12

5. C-Reactive Protein as an Early Predictor of Efficacy in Advanced Non-Small-Cell Lung Cancer Patients: A Tumor Dynamics-Biomarker Modeling Framework;Cancers;2023-11-15